CIK: 0001388551 · Show all filings
Period: Q2 2013 (← Previous) (Next →)
Filing Date: Aug 14, 2013
Total Value ($000): $118,178 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SYNTA PHARMACEUTICALS CORP | 23,631,849 | $117,923 | 99.8% | $8.49 | — | COM | 87162T206 |
| — | HALLMARK FINL SVCS INC EC | 27,900 | $255 | 0.2% | $9.39 | — | COM NEW | 40624Q203 |